| ARCT latest price $46.1300 (-0.3%) ($45.2900 - $47.6000) on Mon. Nov. 30, 2015. |
|
|
| Trend Analysis and Forecast |
| |
Average Daily Percentage Swing | 4.45% (three month average) |
RSI | 28 |
Latest Price | $46.1300(-0.3%) |
Stocks Behave Similarly | Similar Stock List |
Daily Trend | ARCT advances 1.2% a day on average for past five trading days. |
Weekly Trend | ARCT declines -5.1% a week on average for past two weeks. |
Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. |
Correlated ETFs | Broad market will support ARCT advance at 0% a week (0% probability) IBB(4%) XBI(3%) XLV(3%) ARKG(2%) IWM(2%) |
Factors Impacting ARCT price | ARCT will decline at least -2.225% in a week (0% probabilities). VCIT(-5%) LQD(-5%) VIXM(-4%) CEMB(-4%) XLU(-3%) |
Explanation | The rally is not sustainable and not supported by the broad market. |
| |
| |
Relative Volatility | (options are extremely cheap) |
| |
Market Trend Strength | -2.225% (StdDev 4.45%) |
Hourly BBV | 0 () |
Intraday Trend | -0.8% |
| |
|
|
July 7, 2020 ARCT develops mRNA based covid vaccine. Now it's still in preclinical stage, and plan to start phase I clinic trail this summer.